Ramos Jose C, Chukus Anjeza
Diagnostic Radiology, Hospital Corporation of America (HCA) Florida Aventura Hospital, Aventura, USA.
Neuroradiology and Breast Imaging, Hospital Corporation of America (HCA) Florida Aventura Hospital, Aventura, USA.
Cureus. 2025 Jun 5;17(6):e85418. doi: 10.7759/cureus.85418. eCollection 2025 Jun.
Myofibroblastoma (MFB) of the breast is a rare benign mesenchymal tumor originating from mammary stromal cells, posing diagnostic challenges due to its diverse presentation. It typically affects older individuals, often postmenopausal women and men aged 40-87 years, presenting as a solitary, painless, well-defined, mobile mass that grows slowly. On mammography, MFB typically manifests as a well-circumscribed, non-calcified, round or oval mass, often of equal or high density, though margins can sometimes be obscured or indistinct, and rare coarse calcifications have been reported. Ultrasound findings are variable but often demonstrate a solid, irregular, non-circumscribed mass with varying posterior acoustic features and vascularity. Diagnosing MFB requires core needle biopsy and immunohistochemistry, as imaging findings are non-specific. However, MFB encompasses a broad morphologic spectrum beyond the classic spindle cell type and sometimes demonstrate mixed variants that can exhibit unusual or alarming features that make diagnosis challenging. A key feature is the presence of interspersed thick, hyalinized, and eosinophilic collagen bundles. Immunohistochemically, MFB characteristically shows strong positivity for CD34 and desmin. Treatment involves surgical excision, which is curative, and the prognosis is excellent with an extremely low risk of recurrence and no metastatic potential. Accurate differentiation from malignant mimics, particularly invasive lobular carcinoma and metaplastic carcinoma, is crucial. This case report describes a 41-year-old female who was found to have a suspicious right breast mass on a diagnostic ultrasound, later confirmed as MFB through pathology. Given the rarity of MFB, this case underscores the importance of accurate diagnosis and a multidisciplinary approach involving radiology, pathology, and surgery for appropriate management.
乳腺肌纤维母细胞瘤(MFB)是一种罕见的良性间叶组织肿瘤,起源于乳腺基质细胞,因其表现多样而带来诊断挑战。它通常影响老年个体,常见于绝经后女性以及40至87岁的男性,表现为单个、无痛、边界清晰、可活动的肿块,生长缓慢。在乳腺钼靶检查中,MFB通常表现为边界清晰、无钙化的圆形或椭圆形肿块,密度常等于或高于周围组织,不过有时边界可能模糊不清,也有报道称存在罕见的粗大钙化。超声检查结果各异,但通常显示为实性、不规则、边界不清的肿块,具有不同的后方回声特征和血管分布。诊断MFB需要进行粗针活检和免疫组织化学检查,因为影像学表现不具有特异性。然而,MFB的形态学范围超出了经典的梭形细胞类型,有时还会表现出混合变体,可能具有不寻常或令人担忧的特征,这使得诊断具有挑战性。一个关键特征是存在散在的粗大、玻璃样变和嗜酸性的胶原束。免疫组织化学方面,MFB特征性地显示CD34和结蛋白呈强阳性。治疗方法为手术切除,可治愈,预后极佳,复发风险极低且无转移潜能。准确鉴别恶性模仿者,尤其是浸润性小叶癌和化生性癌,至关重要。本病例报告描述了一名41岁女性,其在诊断性超声检查中发现右乳有可疑肿块,后来通过病理证实为MFB。鉴于MFB的罕见性,该病例强调了准确诊断以及采用包括放射学、病理学和外科学的多学科方法进行恰当管理的重要性。